Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Moderate Buy" from Analysts

Teleflex Incorporated (NYSE:TFX - Get Free Report) has been given an average rating of "Moderate Buy" by the ten research firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $267.50.

Several research firms have commented on TFX. Royal Bank of Canada dropped their price target on shares of Teleflex from $272.00 to $265.00 and set an "outperform" rating for the company in a research note on Friday, February 23rd. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 23rd. JMP Securities restated a "market outperform" rating and set a $285.00 target price on shares of Teleflex in a research report on Friday, February 23rd. Finally, Truist Financial dropped their price objective on shares of Teleflex from $270.00 to $265.00 and set a "hold" rating for the company in a research note on Friday, February 23rd.

Read Our Latest Stock Report on TFX


Insider Activity at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the company's stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares in the company, valued at approximately $2,261,250. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 1.43% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Allworth Financial LP boosted its holdings in Teleflex by 332.3% in the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company's stock valued at $26,000 after purchasing an additional 103 shares during the period. Venturi Wealth Management LLC acquired a new stake in Teleflex in the 3rd quarter valued at about $27,000. Covestor Ltd grew its position in shares of Teleflex by 305.6% during the 3rd quarter. Covestor Ltd now owns 146 shares of the medical technology company's stock worth $29,000 after buying an additional 110 shares during the period. Riverview Trust Co acquired a new stake in shares of Teleflex during the 1st quarter worth approximately $31,000. Finally, Lindbrook Capital LLC grew its position in shares of Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company's stock worth $34,000 after buying an additional 58 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Trading Down 0.4 %

NYSE:TFX traded down $0.82 during midday trading on Friday, hitting $206.56. The stock had a trading volume of 415,546 shares, compared to its average volume of 259,078. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $9.73 billion, a price-to-earnings ratio of 27.43, a PEG ratio of 1.99 and a beta of 1.11. The stock has a 50-day moving average of $225.49 and a 200 day moving average of $225.15. Teleflex has a one year low of $177.63 and a one year high of $276.43.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts' consensus estimates of $3.26 by $0.12. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The business had revenue of $773.90 million during the quarter, compared to analyst estimates of $769.01 million. During the same quarter last year, the business posted $3.52 EPS. The company's revenue was up 2.1% on a year-over-year basis. As a group, sell-side analysts forecast that Teleflex will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.66%. The ex-dividend date was Thursday, February 29th. Teleflex's dividend payout ratio is presently 18.06%.

About Teleflex

(Get Free Report

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Read More

Analyst Recommendations for Teleflex (NYSE:TFX)

Should you invest $1,000 in Teleflex right now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: